Prism Medico and Pharmacy share news, announcements and annual reports
Share price at the BSE close on 28 Oct 2026. Previous close ₹35.00.
28 Oct: open ₹34.79, high ₹35.88, low ₹32.60
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹48 Cr4,315th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −2.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −2.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 16,688
Prism Medico and Pharmacy has 816 announcements on record, routine notices left out; 2 in the 30 days to 29 Oct 2026, the latest on 5 Oct 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Prism Medico and Pharmacy quarterly results
The board met on 12 Aug 2026 to consider quarterly results
Notice filed 5 Aug 2026
Prism Medico and Pharmacy annual reports, presentations and earnings calls
The company's own documents, latest first.Prism Medico and Pharmacy financials, year by year
Annual reports23
- Annual report, year to Mar 202626 Aug 2026
- Annual report, year to Mar 20256 Sep 2025
- Annual report, year to Mar 20235 Sep 2023
- Annual report, year to Mar 20227 Sep 2022
- Annual report, year to Mar 202126 Aug 2021
18 earlier reports
- Annual report, year to Mar 202018 Aug 2020
- Annual report, year to Mar 20195 Sep 2019
- Annual report, year to Mar 20181 Oct 2018
- Annual report, year to Mar 201722 Sep 2017
- Annual report, year to Mar 20161 Oct 2016
- Annual report, year to Mar 20158 Jun 2016
- Annual report, year to Mar 20149 Sep 2014
- Annual report, year to Mar 20135 Sep 2013
- Annual report, year to Mar 20126 Sep 2012
- Annual report, year to Mar 201111 Nov 2011
- Annual report, year to Mar 2010Filing day not known
- Annual report, year to Mar 2009Filing day not known
- Annual report, year to Mar 2008Filing day not known
- Annual report, year to Mar 2007Filing day not known
- Annual report, year to Mar 2006Filing day not known
- Annual report, year to Mar 2005Filing day not known
- Annual report, year to Mar 2004Filing day not known
- Annual report, year to Mar 2003Filing day not known
Prism Medico and Pharmacy share news and announcements
Newest first. Page 1 of 17.
Oct 2026
5 Oct · Compliance-57 (5) : intimation after the end of quarter
Sep 2026
30 Sep · Compliance-57 (4) : Prior intimation to the beginning of the quarter
Aug 2026
24 Aug · Annual Report For The Financial Year 2025-2026.
19 Aug · Board meeting
Meeting on 24 Aug 20265 Aug · Board meeting
Meeting on 12 Aug 2026: quarterly results
Jul 2026
21 Jul · Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
6 Jul · Compliance-57 (5) : intimation after the end of quarter
Jun 2026
30 Jun · Compliance-57 (4) : Prior intimation to the beginning of the quarter
May 2026
25 May · Board meeting
Meeting on 28 May 2026: audited results5 May · Board meeting
Meeting on 5 May 20265 May · Announcement under Regulation 30 (LODR)-Allotment
Apr 2026
21 Apr · Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
7 Apr · Compliance-57 (5) : intimation after the end of quarter
6 Apr · Compliance-57 (5) : intimation after the end of quarter
Mar 2026
30 Mar · Intimation Under Regulation 57(4) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
19 Mar · Publication Of Corrigendum To Notice To Shareholders.
Feb 2026
23 Feb · Legal
Exchange has sought clarification from Prism Medico and Pharmacy Ltd on February 23, 2026 with reference to significant movement in price, in order to ensure that investors have latest ....18 Feb · Board meeting
Meeting on 23 Feb 2026: preferential issue of shares9 Feb · Board meeting
Meeting on 13 Feb 2026: quarterly results
Jan 2026
30 Jan · Undertaking Of Functional Website
16 Jan · Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
2 Jan · Compliance-57 (5) : intimation after the end of quarter
Dec 2025
31 Dec · Intimation Under Regulation 57(4) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 18 May 2023Board or managers changeddown 2.94%−2.5 pts vs Nifty 500market median 0.0% · five sessions +1.9% (+1.3 pts vs Nifty 500) · volume 0.3× usual · The announcement
- 17 May 2023Board or managers changeddown 0.33%+0.1 pts vs Nifty 500market median 0.0% · five sessions +1.9% (+1.5 pts vs Nifty 500) · volume 0.5× usual · The announcement
- 9 Jul 2021Board or managers changeddown 4.93%−4.9 pts vs Nifty 500market median 0.0% · five sessions +8.7% (+7.3 pts vs Nifty 500) · volume 1.8× usual · The announcement
- 11 Nov 2020Board or managers changedup 3.31%+2.5 pts vs Nifty 500market median 0.0% · five sessions +19.4% (+16.9 pts vs Nifty 500) · volume 0.6× usual · The announcement
- 30 Dec 2019Board or managers changeddown 0.72%−0.9 pts vs Nifty 500market median 0.0% · five sessions −4.3% (−4.6 pts vs Nifty 500) · volume 0.0× usual · The announcement
- 3 Nov 2014Board or managers changedup 2.47%+2.2 pts vs Nifty 500market median 0.0% · five sessions +1.2% (+0.2 pts vs Nifty 500) · volume 1.6× usual
- 10 Sep 2014Board or managers changedup 4.88%+5.4 pts vs Nifty 500market median 0.0% · five sessions +15.2% (+17.7 pts vs Nifty 500) · volume 2.6× usual
- 25 Aug 2014Board or managers changeddown 0.28%0.0 pts vs Nifty 500market median 0.0% · five sessions −5.3% (−6.6 pts vs Nifty 500) · volume 1.0× usual
- 17 Jul 2014Board or managers changeddown 2.45%−3.0 pts vs Nifty 500market median 0.0% · five sessions −3.8% (−5.6 pts vs Nifty 500) · volume 1.6× usual
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Earnings per share, continuing businesses | Year to date to Dec 2024 | Standalone | 0.00 | −0.02 | −900.0% | 14 Feb 2025 | 10 Jun 2025 |
| Diluted earnings per share, continuing businesses | Year to date to Dec 2024 | Standalone | 0.00 | −0.02 | −900.0% | 14 Feb 2025 | 10 Jun 2025 |
| Earnings per share | Year to date to Dec 2024 | Standalone | 0.00 | −0.02 | −900.0% | 14 Feb 2025 | 10 Jun 2025 |
| Diluted earnings per share | Year to date to Dec 2024 | Standalone | 0.00 | −0.02 | −900.0% | 14 Feb 2025 | 10 Jun 2025 |